The multiple actions of selegiline.
Ebadi
Manuchair
M
Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota, School of Medicine and Health Sciences, P.O. Box 9037, 501 North Columbia Road, Grand Forks, ND 58203, USA. medbadi@medicine.nodak.edu
Sharma
Sushil
S
Shavali
Shaik
S
Sangchot
Patcharee
P
Brekke
Leah
L
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D004298:Dopamine / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000502:physiology; D005260:Female; D018698:Glutamic Acid / Q000633:toxicity; D020267:MPTP Poisoning / Q000517:prevention & control; D008636:Mesencephalon / Q000166:cytology / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000188:drug therapy; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D012642:Selegiline / Q000494:pharmacology*
D000978:Antiparkinson Agents; D008996:Monoamine Oxidase Inhibitors; D018696:Neuroprotective Agents; D012642:Selegiline; D018698:Glutamic Acid; D004298:Dopamine